Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 368 results found. Search for [ Dr Reddy's Laboratories ]

Results 100 to 120 of 368
by E Kumar Sharma
Delhi, January 21, 2017
Top pharma companies - Driven by inorganic growth opportunities - are also learning to live with more debt.


Reuters
January 9, 2017
Market was flat on Monday as the quarterly reporting season kicked in, with investors concerned that the government's move to ban high-value notes would hit corporate earnings. Software bellwether Tata Consultancy Services Ltd is due to report results on Thursday, while rival Infosys will do so on Friday.


by E. Kumar Sharma
Delhi, December 26, 2016
E-governance is the watchword in Andhra Pradesh and Telangana, both of which have launched unique digital initiatives.


Reuters
December 16, 2016
Drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after it was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly-used drugs in the United States.


by P.B. Jayakumar
Delhi, December 12, 2016
Torrent Pharmaceuticals was a late entrant to the US, but Samir Mehta has led it to fast-paced growth in that market.


Reuters
November 4, 2016
Indian drug makers, most of which count the United States as their biggest export market, were the top losers on the key indexes on Friday.


BT Online
New Delhi, November 4, 2016
The Sensex fell further after the reports of criminal investigation of generic makers over suspected price collusion and closed  156 points lower.


By E. Kumar Sharma,E Kumar Sharma
Delhi, October 29, 2016
Many major pharma stocks, seen as safe bets in the worst of times, have seen their market caps slip in the past year. Is pharma losing its sheen on the bourses?


PTI
New Delhi, October 25, 2016
DRL's total income from operation on consolidated basis was down 10.05 per cent to Rs 361.63 crore as against Rs 402.07 crore in the corresponding quarter last fiscal.


E Kumar Sharma
October 10, 2016
Leading global consultancy firms like Lachman Consultants, Parexel and Quintiles (now QuintilesIMS), have been in demand in India with pharmaceutical companies seeking their services to resolve regulatory compliance issues.


By Joe C. Mathew
Delhi, October 5, 2016
One of the earliest diagnoses made by Sun Pharma in the run-up to the Ranbaxy acquisition was that since the entire management was focusing on resolving the US FDA's negative observations, there was a lack of focus towards expanding the business.


Reuters
September 29, 2016
A short drive from the bustling tech hub of Hyderabad, Medak is the heart of India's antibiotics manufacturing business: a district of about 2.5 million that has become one of the world's largest suppliers of cheap drugs to most markets, including the United States.


PTI
August 1, 2016
Pharma major Cipla has appointed Kedar Upadhye as its Global chief financial officer (CFO) effective from Monday.


PTI
Mumbai, July 27, 2016
At NSE, shares of the company plunged 10.22 per cent to end at Rs 2,980.20. The stock was the biggest loser among the bluechips on both Sensex and Nifty during the day. The company's market valuation dipped by Rs 5,529.15 crore to Rs 49,473.85 crore.


E Kumar Sharma
July 26, 2016
Afterall, its net profit for the quarter was down 80 per cent PAT touching Rs 126.3 crore as against Rs 625.7 crore in the corresponding period of the previous year.


Reuters
July 26, 2016
Net profit for the April-June quarter fell to Rs 154 crore ($22.89 million) from Rs 626 crore in the previous year, and missed a Thomson Reuters I/B/E/S estimate of Rs 495 crore from 17 analysts.


Karan Dhar
July 19, 2016
As the slump in oil prices pushes Venezuela's economy closer to a depression, ordinary Venezuelans are finding it difficult to buy the basic food items. According to media reports, more than 100,000 Venezuelans crossed into Colombia over the weekend to hunt for food and medicine.


PTI
New Delhi, July 6, 2016
According to the latest Enforcement Report of United States Food and Drug Administration (USFDA) Lupin's US arm-Lupin Pharmaceuticals Inc-is recalling 59,520 bottles of Lisinopril & Hydrochlorothiazid tablets USP 20mg/12.5mg, 5,880 bottles of Lisinopril tablets, USP 40 mg and 20,587 bottles of Lisinopril tablets, USP 30mg due to deviation from current good manufacturing practice (CGMP).


E Kumar Sharma
June 14, 2016
The deal, which cost Dr. Reddy's $350 million, translates into around $45 million paid for each product.


BT Online
New Delhi, June 13, 2016
Shares of Amtek Auto soared over 4.91 per cent on BSE after the company reported that the automobile component maker was close to selling its profitable German unit, Tekfor, for about $700 million (Rs 4,690 crore) to a foreign buyer in order to cut its debt.


PAGES 6 OF 19  678910